DMAC - CIK 0001401040
DiaMedica Therapeutics Inc. (DMAC) reported revenue of $500.00K for fiscal year 2018, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2018 | $500.00K | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.